DOCSLIB.ORG

Risk of First Trimester Spontaneous Miscarriage Among Singleton

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Middle East Fertility Society Journal (2013) xxx, xxx–xxx Middle East Fertility Society Middle East Fertility Society Journal www.mefsjournal.org www.sciencedirect.com ORIGINAL ARTICLE Risk of first trimester spontaneous miscarriage among singleton gestations following ICSI and its relation to underlying cause of infertility Wessam Magdi Abuelghar a,*, Osama Saleh Elkady a, Tarek Fathi. Tamara a, Mona Hassan Khalil b a Obstetrics and Gynaecology Department, Ain-shams University, Cairo, Egypt b Obstetrics and Gynaecology Department, El Khazendara MOH Hospital, Cairo, Egypt Received 16 April 2013; accepted 12 June 2013 KEYWORDS Abstract Study objective: To assess the association between the first trimester miscarriage rates Miscarriage; among women undergoing intracytoplasmic sperm injection (ICSI) and underlying etiology of ICSI; infertility. Infertility Design: Prospective cohort study. Setting: Ain Shams University maternity hospital. Materials and methods: The study included women who became pregnant with singleton preg- nancy following ICSI as a treatment for different causes of infertility. Women were followed up throughout the first trimester of pregnancy up to 12 weeks’ gestation (10 weeks after the day of embryo transfer). Main outcome measure: First trimester miscarriage rate. Results: Two hundred and thirty four pregnant young women were included in the study, 164 (70.9%) women miscarried. The causes of infertility among these women were as follows: 41 (25%) mild male factor infertility, 40 (24.4%) severe male factor infertility, 45 (27.44%) tubal fac- tor, 7 (4.27%) polycystic ovarian syndrome, 3 (1.83%) endometriosis, 20 (12.19%) unexplained and Abbreviations: BMI, body mass index; CI, confidence interval; E2, estradiol; ET, embryo transfer; FSH, follicle stimulating hormone; GnRH, gonadotropin-releasing hormone; hCG, human chorionic gonadotropin; ICSI, intracytoplasmic sperm injection; IVF, in vitro fertilization; LH, luteinizing hormone; LMP, last menstrual period; OR, odds ratio; SD, standard deviation * Corresponding author. Tel.: +20 1227460679. E-mail address: [email protected] (W.M. Abuelghar). Peer review under responsibility of Middle East Fertility Society. Production and hosting by Elsevier 1110-5690 Ó 2013 Production and hosting by Elsevier B.V. on behalf of Middle East Fertility Society. http://dx.doi.org/10.1016/j.mefs.2013.06.005 Please cite this article in press as: Abuelghar WM et al. Risk of first trimester spontaneous miscarriage among singleton gestations following ICSI and its relation to underlying cause of infertility, Middle East Fertil Soc J (2013), http://dx.doi.org/10.1016/j.mefs.2013.06.005 2 W.M. Abuelghar et al. 8 (4.87%) multifactorial. Stepwise logistic multi-regression analysis showed that both maternal age (>31 years) and tubal block were the most sensitive discriminators for the prediction of first trimes- ter spontaneous miscarriage among the study population (P < 0.01). Major conclusions: First trimester spontaneous miscarriage rates among pregnant women with singleton pregnancy following ICSI were related to maternal age >31 years and/or the presence of tubal block. Ó 2013 Production and hosting by Elsevier B.V. on behalf of Middle East Fertility Society. 1. Introduction According to the underlying cause of infertility, all women were categorized. Tubal factor diagnosis was confirmed by Miscarriage is the most frequent complication of pregnancy hysterosalpingography, and or pelvic laparoscopy and male and it is assumed that fetal viability is only achieved in 30% factor infertility was diagnosed by semen criteria meeting the of all pregnancies, 50% of which are lost prior to the first World Health Organization (1999) criteria (7,8). Mild oligozo- 6 missed period (1). Gestational age, maternal age, previous his- ospermia (1–19 · 10 sperm/ml) was considered as mild male 6 tory of miscarriage and smoking are the major risk factors for factor and severe oligozoospermia (<10 sperm/ml) was con- miscarriage (2). sidered as severe male factor. Polycystic ovary syndrome ICSI (intracytoplasmic sperm injection) is a microscopic (PCOS) was diagnosed according to Rotterdam criteria [2 maneuver used to facilitate fertilization by injecting a single out of 3 from the following: 1. Oligo- or anovulation, 2. Clin- sperm directly into the oocyte (3). Achievement of pregnancy ical and/or biochemical signs of hyperandrogenism, 3. Polycys- in ICSI cycles is a real confrontation to physicians as it is tic ovaries by transvaginal sonography (presence of 12 or more the last and most advanced track in the management of infer- follicles in each ovary measuring 2–9 mm in diameter, and/or tility till now. Although there was a great advancement in the increased ovarian volume >10 ml)] (9). Endometriosis was success rate in the last few years, a range between 30% and diagnosed by either the presence of endometrioma(s) by trans- 40% is never pleasing to both physicians and patients (4). vaginal ultrasound and/or the laparoscopic criteria of the Moreover, miscarriage meaningfully reduces the initial success American Fertility Society classification (10). Infertility was and capability of ICSI treatment, increasing the psychological diagnosed as unexplained if all of the following were within grievance of patients (5). Since chromosomal aberrations (fre- normal: mid-luteal serum progesterone level for the detection quently aneuploidy) have been accounted for 50–75% of mis- of ovulation, hysterosalpingography and/or laparoscopy for carriages during the first trimester of gestation, one measurable tubal patency and semen analysis (11). According to our local outcome to authenticate the safety of ICSI can be the rate of institutional protocol, long mid-luteal protocol was applied in miscarriage among ICSI pregnancies (6). The differences in all cycles. Down regulation was done using gonadotropin- Ò miscarriage rates in ICSI are not completely understood and releasing hormone (GnRH) agonist (Decapeptyl 0.1 mg, Fer- may emanate from predisposing factors that are more preva- ring, Switzerland) starting from day 17 of the previous cycle. lent in patients suffering from infertility (5). The aim of the GnRH agonist was taken as a single subcutaneous injection till current work was to assess the association between underlying day two of the treatment cycle when the dose was reduced to etiology of infertility and first trimester miscarriage rates half the dose till the day of human chorionic gonadotropin among women who underwent intracytoplasmic sperm injec- (hCG) injection. tion (ICSI). The induction of ovulation was done using gonadotropin hormones, 75 IU FSH, 75 IU LH (MerionalÒ,IBSA,Switzer- land), starting from cycle day two calculated according to age, 2. Materials and methods weight and antral follicle count, then the dose was fashioned according to each patient’s response as monitored by follicul- The current prospective study was conducted at the assisted ometry. Embryo transfer had been carried for all cases on the reproduction unit of Ain Shams University maternity hospital 3rd day post ovum pick up. After embryo-transfer, 100 mg from January 2009 to December 2011 and included young intramuscular daily progesterone was given to all women for pregnant women with singleton pregnancy, proved by trans- 8 weeks as a luteal phase support (ProntogestÒ,EIPICOfor vaginal ultrasound, following ICSI as a treatment for different Marcyrl Pharmaceutical Industries, Egypt). Quantitative hCG causes of infertility. Women were followed up throughout the was done 2 weeks later to diagnose chemical pregnancy, and first trimester of pregnancy up to 12 weeks’ gestation (10 weeks once more after 48 h to ensure the doubling pattern, then trans- after the day of embryo transfer). All couples were thoroughly vaginal ultrasound (TVUS) was performed 2 weeks after posi- informed about the treatment procedures, and written in- tive pregnancy tests to confirm the presence of gestational sac formed consent was obtained from all women. The treatment with fetal echo and pulsation and to exclude ectopic pregnancy. protocols were approved by the Ethics Committee of Ain Once more TVUS was performed at 12 weeks gestation to deter- Shams University maternity Hospital, Cairo, Egypt in accor- mine the main outcome measure, early pregnancy failure. dance with local institutional research governance require- The diagnosis of early pregnancy failure was based on the ments. Couples who had frozen–thawed embryo transfers, a findings of obstetric ultrasound examination(s). First trimester history of recurrent pregnancy failure (3 or more miscarriages), missed miscarriage was defined as an intact gestational sac structural or numerical chromosomal aberrations were ex- lacking any fetal cardiac pulsation [6 weeks after last men- cluded. Women with any medical disorders and/or having con- strual period (LMP)], intrauterine gestational sac with the larg- genital malformation of the uterus were also excluded. est diameter more than 10 mm in the absence of yolk sac or an Please cite this article in press as: Abuelghar WM et al. Risk of first trimester spontaneous miscarriage among singleton gestations following ICSI and its relation to underlying cause of infertility, Middle East Fertil Soc J (2013), http://dx.doi.org/10.1016/j.mefs.2013.06.005 Spontaneous miscarriage among singleton gestations following ICSI 3 Figure 1 Participants flowchart. empty gestational sac with a sure confirmed gestational age of ences) software version 17.0. Descriptive statistics were done
Recommended publications
  • Anti-Chalmydial Antibody As a Predictive Test for Tubal Factor Infertility

    Anti-Chalmydial Antibody As a Predictive Test for Tubal Factor Infertility

    Al-Azhar Med. J. Vol. 49(1), January, 2020, 229-240 DOI : 10.12816/amj.2020.67131 https://amj.journals.ekb.eg/article_67131.html ANTI-CHALMYDIAL ANTIBODY AS A PREDICTIVE TEST FOR TUBAL FACTOR INFERTILITY By Emad A. El-Tamamy, Ashraf H. Mohamed, Wael R. Hablas* and Shaban H. Abd El-Rahman ** Departments of Obstetrics & Gynecology and Clinical Pathology*, Faculty of Medicine, Al-Azhar University **Corresponding E-mail: [email protected] ABSTRACT Background: Infertility is a common gynaecological problem that has a multi factorial aetiology. Conception and pregnancy depend on complex physiological, anatomic and immunological factors. Objective: to evaluate the prevalence of chlamydial infection, especially subclinical cases, in a population of Egyptian tubal infertile women and to relate it to history, symptoms, clinical, and laparoscopy findings. Finally, to find any advantage of detecting antichlamydial antibodies in serum of these patients and evaluate its importance in prediction of tubal factor of infertility. Patients and Methods: This study includes 50 primary or secondary infertile females (patients group) their age between 20-30 years, and 50 random fertile females (control group) and Blood sample for IgG, Chlamydia trachomatis antibodies were drawn from all cases of the study for ELISA test. Results: The prevalence rate of Chlamydia trachomatis IgG antibodies was significantly higher in infertile group than that of control group. There was significant higher rate and ratio of positive results in infertile group than that of control group concerning anti-chlamydial IgG. There was a strong correlation between serum levels of anti-chlamydial IgG in the infertility patients. There was a significant correlation between serum anti-chlamydial IgG levels and the duration of infertility.
  • Detection of Mycoplasma Genitalium in Women with Laparoscopically

    Detection of Mycoplasma Genitalium in Women with Laparoscopically

    463 MYCOPLASMA GENITALIUM Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis C R Cohen, N R Mugo, S G Astete, R Odondo, L E Manhart, J A Kiehlbauch, W E Stamm, P G Waiyaki, P A Totten ............................................................................................................................... Sex Transm Infect 2005;81:463–466. doi: 10.1136/sti.2005.015701 Objectives: Mycoplasma genitalium has been associated with cervicitis, endometritis, and tubal factor See end of article for infertility. Because the ability of this bacterium to ascend and infect the fallopian tube remains undefined, authors’ affiliations we performed an investigation to determine the prevalence of M genitalium in fallopian tube, endometrial, ....................... and cervical specimens from women laparoscopically diagnosed with acute salpingitis in Nairobi, Kenya. Correspondence to: Methods: Women presenting with pelvic inflammatory disease were laparoscopically diagnosed with Craig R Cohen, MD, MPH, salpingitis. Infection with M genitalium in genital specimens was determined by polymerase chain reaction 74 New Montgomery Street, Suite 600, UCSF, (PCR). Box 0886, San Francisco, Results: Of 123 subjects with acute salpingitis, M genitalium was detected by PCR in the cervix and/or CA 94105, USA; ccohen@ endometrium in nine (7%) participants, and in a single fallopian tube specimen. In addition, those infected psg.ucsf.edu with M genitalium were more often HIV infected than women not infected by M genitalium (seven of nine Accepted for publication (78%) v 42 of 114 (37%), p,0.03). 26 April 2005 Conclusions: M genitalium is able to ascend into the fallopian tube, but its association with tubal pathology ....................... requires further investigation. elvic inflammatory disease (PID) is the most common the female upper genital tract and cause tubal disease has not serious gynaecological disorder diagnosed in women and been firmly established.
  • Tubal Damage, Infertility and Tubal Ectopic Pregnancy: Chlamydia Trachomatis and Other Microbial Aetiologies

    Tubal Damage, Infertility and Tubal Ectopic Pregnancy: Chlamydia Trachomatis and Other Microbial Aetiologies

    2 Tubal Damage, Infertility and Tubal Ectopic Pregnancy: Chlamydia trachomatis and Other Microbial Aetiologies Louise M. Hafner and Elise S. Pelzer Institute of Health and Biomedical Innovation, (IHBI), Queensland University of Technology (QUT) Australia 1. Introduction Infertility is a worldwide health problem with one in six couples suffering from this condition and with a major economic burden on the global healthcare industry. Estimates of the current global infertility rate suggest that 15% of couples are infertile (Zegers- Hochschild et al., 2009) defined as: (1) failure to conceive after one year of unprotected sexual intercourse (i.e. infertility); (2) continual failure of implantation at subsequent cycles of assisted reproductive technology; or (3) persistent miscarriage events without difficulty conceiving (natural conceptions). Tubal factor infertility is among the leading causes of female factor infertility accounting for 7-9.8% of all female factor infertilities. Tubal disease directly causes from 36% to 85% of all cases of female factor infertility in developed and developing nations respectively and is associated with polymicrobial aetiologies. One of the leading global causes of tubal factor infertility is thought to be symptomatic (and asymptomatic in up to 70% cases) infection of the female reproductive tract with the sexually transmitted pathogen, Chlamydia trachomatis. Infection-related damage to the Fallopian tubes caused by Chlamydia accounts for more than 70% of cases of infertility in women from developing nations such as sub-Saharan Africa (Sharma et al., 2009). Bacterial vaginosis, a condition associated with increased transmission of sexually transmitted infections including those caused by Neisseria gonorrhoeae and Mycoplasma genitalium is present in two thirds of women with pelvic inflammatory disease (PID).
  • Population Attributable Fraction of Tubal Factor Infertility Associated with Chlamydia

    Population Attributable Fraction of Tubal Factor Infertility Associated with Chlamydia

    HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Am J Obstet Manuscript Author Gynecol. Author Manuscript Author manuscript; available in PMC 2018 September 01. Published in final edited form as: Am J Obstet Gynecol. 2017 September ; 217(3): 336.e1–336.e16. doi:10.1016/j.ajog.2017.05.026. Population Attributable Fraction of Tubal Factor Infertility Associated with Chlamydia Rachel J. GORWITZ, MD, MPH1, Harold C. WIESENFELD, MD, CM2,3, Pai Lien CHEN, PhD4, Ms. Karen R. HAMMOND, DNP, CRNP5, Ms. Karen A. SEREDAY, MS1, Catherine L. HAGGERTY, PhD, MPH3,6, Robert E. JOHNSON, MD, MPH1, John R. PAPP, PhD1, Dmitry M. KISSIN, MD, MPH1, Tara C. HENNING, PhD1, Edward W. HOOK III, MD7, Michael P. STEINKAMPF, MD, MA5, Lauri E. MARKOWITZ, MD1, and William M. GEISLER, MD, MPH7 1Centers for Disease Control and Prevention, Atlanta, GA 2Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA 3Magee-Womens Research Institute, Pittsburgh, PA 4FHI360, Durham, NC 5Alabama Fertility Specialists, Birmingham, AL 6Department of Epidemiology, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA 7Department of Medicine, University of Alabama at Birmingham, Birmingham, AL Abstract Background—Chlamydia trachomatis infection is highly prevalent among young women in the United States. Prevention of long-term sequelae of infection, including tubal factor infertility, is a primary goal of chlamydia screening and treatment activities. However, the population attributable fraction of tubal factor infertility associated with chlamydia is unclear, and optimal measures for assessing tubal factor infertility and prior chlamydia in epidemiologic studies have not been established. Black women have increased rates of chlamydia and tubal factor infertility compared Corresponding author: Rachel J.
  • Increased Prevalence of Endocervical Mycoplasma and Ureaplasma Colonization in Infertile Women with Tubal Factor

    Increased Prevalence of Endocervical Mycoplasma and Ureaplasma Colonization in Infertile Women with Tubal Factor

    JBRA Assisted Reproduction 2020;24(2):152-157 doi: 10.5935/1518-0557.20190078 Original article Increased prevalence of endocervical Mycoplasma and Ureaplasma colonization in infertile women with tubal factor Rita CCP Piscopo1, Ronney V Guimarães1, Joji Ueno1,2, Fabio Ikeda1,2, Zsuzsanna IK Jarmy-Di Bella3, Manoel JBC Girão3, Marise Samama1,3 1Clinical Department, Instituto Gera de Medicina Reprodutiva, São Paulo, SP, Brazil 2Video-Hysteroscopy Section, Hospital Sírio Libanês, São Paulo, SP, Brazil 3Gynecology Department, Universidade Federal de São Paulo - Escola Paulista de Medicina, São Paulo, SP, Brazil This study was presented as a poster at the ESHRE Annual Meeting 2018, held in Barcelona – Spain on July 01-04, 2018 ABSTRACT damage seems to be the foremost way in which infections Objective: Most women suffering from tubal factor in- affect women’s fertility. Pathogenic microorganisms colo- fertility do not have a history of pelvic inflammatory dis- nizing the lower female genital tract may ascend to the ease, but rather have asymptomatic upper genital tract in- upper genital tract, causing pelvic inflammatory disease fection. Investigating the impacts of such infections, even (PID) associated with tubal damage, and ultimately to in- in the absence of clinically confirmed pelvic inflammatory fertility. In the presence of infection, tubal damage may disease, is critical to understanding the tubal factor of in- occur in response to adhesions, damage to the tubal mu- fertility. The aim of this study was to investigate whether cosa or tubal occlusion impairing oocyte transport (Rho- the presence of endocervical bacteria is associated with ton-Vlasak, 2000). tubal factors in women screened for infertility.
  • Infertility: an Overview

    Infertility: an Overview

    AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE Infertility: An Overview A Guide for Patients PATIENT INFORMATION SERIES Published by the American Society for Reproductive Medicine under the direction of the Patient Education Committee and the Publications Committee. No portion herein may be reproduced in any form without written permission. This booklet is in no way intended to replace, dictate, or fully define evaluation and treatment by a qualified physician. It is intended solely as an aid for patients seeking general information on issues in reproductive medicine. Copyright © 2017 by the American Society for Reproductive Medicine AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE Infertility: An Overview A Guide for Patients, Revised 2017 A glossary of italicized words is located at the end of this booklet. INTRODUCTION Infertility is typically defined as the inability to achieve pregnancy after one year of unprotected intercourse. If you have been trying to conceive for a year or more, you should consider an infertility evaluation. However, if you are 35 years or older, you should consider beginning the infertility evaluation after about six months of unprotected intercourse rather than a year, so as not to delay potentially needed treatment. If you have a reason to suspect an underlying problem, you should seek care earlier. For instance, if you have very irregular menstrual cycles (suggesting that you are not ovulating or releasing an egg), or if you or your partner has a known fertility problem, you probably should not wait an entire year before seeking treatment. If you and your partner have been unable to have a baby, you’re not alone.
  • Role of Tubal Surgery in the Era of Assisted Reproductive Technology: a Committee Opinion

    Role of Tubal Surgery in the Era of Assisted Reproductive Technology: a Committee Opinion

    ASRM PAGES Role of tubal surgery in the era of assisted reproductive technology: a committee opinion The Practice Committee of the American Society for Reproductive Medicine American Society for Reproductive Medicine, Birmingham, Alabama This document reviews surgical options for reparative tubal surgery and the factors that must be considered when deciding between surgical repair and in vitro fertilization. This document replaces the document of the same name, last published in 2012 (Fertil Steril 2015;103:e37–43). This document reviews surgical options for reparative tubal surgery and the factors that must be considered when deciding between surgical repair and in vitro fertilization. (Fertil SterilÒ 2021;115:1143–50. Ó2021 by American Society for Reproductive Medicine.) Key Words: Fallopian tube, hydrosalpinx, sterilization reversal, tubal disease Discuss: You can discuss this article with its authors and other readers at https://www.fertstertdialog.com/posts/32331 ubal disease accounts for 25%– mydia antibody testing is limited by raphy may have a therapeutic effect, T 35% of female factor infertility, false positives from cross-reactivity with higher fecundity rates reported with more than half of the cases with Chlamydia pneumoniae immuno- for several months after the procedure due to salpingitis (1). In addition, large globulin G and does not distinguish be- (11) when tubal flushing was performed studies report that up to 20%–30% of tween remote and persistent infection, with oil-based contrast media (11, 12). women regret having a tubal ligation and it does not indicate whether the The sensitivity of hysterosalpingo- (2–4). Thus, there is a need to infection resulted in tubal damage (5).
  • Sexually Transmitted Diseases and Infertility

    Sexually Transmitted Diseases and Infertility

    HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Am J Obstet Manuscript Author Gynecol. Author Manuscript Author manuscript; available in PMC 2018 January 01. Published in final edited form as: Am J Obstet Gynecol. 2017 January ; 216(1): 1–9. doi:10.1016/j.ajog.2016.08.008. Sexually Transmitted Diseases and Infertility Ms. Danielle G. TSEVAT, BA1, Harold C. WIESENFELD, MD2, Caitlin Parks, MD1, and Jeffrey F. PEIPERT, MD, PhD3 1Washington University in St. Louis School of Medicine, Division of Clinical Research Department of Obstetrics and Gynecology 2Division of General Gynecology, Department of Obstetrics and Gynecology; University of Pittsburgh School of Medicine; Pittsburgh, PA 3Department of Obstetrics and Gynecology; Indiana University School of Medicine; Indianapolis, IN Abstract Female infertility, including tubal factor infertility, is a major public health concern worldwide. Most cases of tubal factor infertility are attributable to untreated sexually transmitted diseases that ascend along the reproductive tract and are capable of causing tubal inflammation, damage, and scarring. Evidence has consistently demonstrated the effects of Chlamydia trachomatis and Neisseria gonorrhoeae as pathogenic bacteria involved in reproductive tract morbidities including tubal factor infertility and pelvic inflammatory disease. There is limited evidence in the medical literature that other sexually transmitted organisms, including Mycoplasma genitalium, Trichomonas vaginalis, and other microorganisms within the vaginal microbiome may be important factors involved in the pathology of infertility. Further investigation into the vaginal microbiome and other potential pathogens is necessary in order to identify preventable causes of tubal factor infertility. Improved clinical screening and prevention of ascending infection may provide a solution to the persistent burden of infertility.
  • Pelvic Inflammatory Disease

    Pelvic Inflammatory Disease

    The new england journal of medicine Review Article Edward W. Campion, M.D., Editor Pelvic Inflammatory Disease Robert C. Brunham, M.D., Sami L. Gottlieb, M.D., M.S.P.H., and Jorma Paavonen, M.D. elvic inflammatory disease is an infection-induced inflammation From the Department of Medicine, Uni- of the female upper reproductive tract (the endometrium, fallopian tubes, versity of British Columbia, Vancouver, 1 Canada (R.C.B.); the Department of Re- ovaries, or pelvic peritoneum); it has a wide range of clinical manifestations. productive Health and Research, World P Health Organization, Geneva (S.L.G.); Inflammation spreads from the vagina or cervix to the upper genital tract, with endometritis as an intermediate stage in the pathogenesis of disease.2 The hall- and the Department of Obstetrics and Gynecology, University of Helsinki, Hel- mark of the diagnosis is pelvic tenderness combined with inflammation of the sinki (J.P.). Address reprint requests to lower genital tract; women with pelvic inflammatory disease often have very subtle Dr. Brunham at the Department of Medi- symptoms and signs.3 Many women have clinically silent spread of infection to the cine, University of British Columbia, 655 1,4 West 12th Ave., Vancouver, BC V5Z 4R4, upper genital tract, which results in subclinical pelvic inflammatory disease. Canada, or at robert . brunham@ bccdc . ca. Pelvic inflammatory disease is a major concern because it can result in long- N Engl J Med 2015;372:2039-48. term reproductive disability, including infertility, ectopic pregnancy, and chronic DOI: 10.1056/NEJMra1411426 pelvic pain. After the introduction of laparoscopy in the 1960s, research on pelvic in- Copyright © 2015 Massachusetts Medical Society.
  • Fertility Solutions Medical Necessity Clinical Guideline: Infertility

    Fertility Solutions Medical Necessity Clinical Guideline: Infertility

    Clinical Performance Guideline Medical Fertility Solutions Necessity Infertility Guideline TABLE OF CONTENTS PURPOSE AND GOAL 2 BACKGROUND 2 GENERAL INDICATIONS 9 TREATMENT CRITERIA 10 OVULATION INDUCTION 10 CLOMID 10 LETROZOLE 10 TAMOXIFEN 11 GONADOTROPINS 11 OVARIAN STIMULATION 12 CLOMID 12 LETROZOLE 12 TAMOXIFEN 12 GONADOTROPINS 13 THERAPEUTIC DONOR INSEMINATION 14 INTRAUTERINE INSEMINATION 15 NATURAL CYCLE 15 STIMULATED IUI 15 ASSISTED REPRODUCTIVE TECHNOLOGIES 16 IVF 16 NATURAL CYCLE IVF 17 ICSI 17 IVF FRESH CYCLE NOT INDICATED 18 ELECTIVE SINGLE EMBRYO TRANSFER 19 MULTIPLE EMBRYO TRANSFER 20 ADJUNCTS TO TREATMENT 21 PREIMPLANTATION GENETIC TESTING 21 GESTATIONAL CARRIER 21 SURGERY 22 TUBAL 22 ENDOMETRIOSIS 23 UTERINE 24 MALE FACTOR INFERTILITY 24 DEFINITIONS 39 BIBLIOGRAPHY 41 This document is proprietary and confidential to Optum® 2021. Effective 07/01/2021 . Unauthorized use or copying without written consent is strictly prohibited. Printed copies are for reference only. TABLE OF CONTENTS 1 Purpose: To provide an understanding of infertility treatment, issues surrounding infertility surgery, and issues surrounding multiple embryo transfers among individuals faced with the potential loss of fertility. Goals: To provide an evidence-based approach to infertility management, infertility surgery, and the use of single embryo transfer in addition to describing the limitations of and recommendations for infertility treatment. Background I. Infertility • Definition: o A disease (an interruption, cessation, or disorder of body functions, systems, or organs) of the reproductive tract which prevents the conception of a child or the ability to carry a pregnancy to delivery. It is defined by the failure to achieve a successful pregnancy after 12 months or more of appropriate, timed unprotected intercourse or Therapeutic Donor Insemination.
  • Genital Tuberculosis Is Common Among Females with Tubal Factor Infertility: Observational Study

    Genital Tuberculosis Is Common Among Females with Tubal Factor Infertility: Observational Study

    Alexandria Journal of Medicine (2015) 51, 321–324 HOSTED BY Alexandria University Faculty of Medicine Alexandria Journal of Medicine http://www.elsevier.com/locate/ajme Genital tuberculosis is common among females with tubal factor infertility: Observational study Abdulhakim Ali Al eryani a, Ahmed Saleh Abdelrub b, Abdelrahman H. Al Harazi c,* a Obstetrics and Gynecology Department, Sana’a University, Al Thawra General Hospital, Sana’a, Yemen b Obstetrics and Gynecology Department, Al Kwait University Hospital, Sana’a, Yemen c Obstetrics and Gynecology Department, Thamar University, Al Thawra General Hospital, PO Box 25244, Yemen Received 17 September 2014; accepted 27 November 2014 Available online 2 January 2015 KEYWORDS Abstract Background: Genital tuberculosis is mostly asymptomatic and infertility is a common Genital tuberculosis; presentation. The study objective was to identify the rate of genital tuberculosis among women with Infertility; tubal factor infertility in non endemic area and to assess the outcome after administration of anti- Polymerase chain reaction tubercular therapy. Methods: We conducted a prospective observational study in Al Thawra General Hospital (from March 2012 to February 2014). Of a total 151 women who had tubal factor infertility, 61 cases were investigated for genital tuberculosis. Women who were found to have the disease were treated by antitubercular therapy and the outcomes were analyzed. Results: We found that 31.1% (47/151) of cases had genital tuberculosis contributing to infertility. Of these, 55.7% (34/61) were positive by histopathology, and 44.1% (15/34) were positive by poly- merase chain reaction. Fallopian tubes were affected in almost all cases and the endometrium was involved in 82.9%.
  • 2013 ART Fertility Clinic Success Rates Report

    2013 ART Fertility Clinic Success Rates Report

    2013Appendix B Glossary of Terms APPENDIX B: GLOSSARY OF TERMS American Society for Reproductive Medicine Donor egg cycle. An embryo is formed from (ASRM). Professional society whose affiliate the egg of one woman (the donor) and then organization, the Society for Assisted Reproductive transferred to another woman (the recipient). Technology (SART), is composed of clinics and The donor relinquishes all parental rights to any programs that provide ART. resulting offspring. ART (assisted reproductive technology). All Donor embryo. An embryo that is donated by a treatments or procedures that include the handling patient or couple who previously underwent ART of human eggs or embryos to help a woman treatment and had extra embryos available. become pregnant. ART includes but is not limited Ectopic pregnancy. A pregnancy in which the to in vitro fertilization (IVF), gamete intrafallopian fertilized egg implants in a location outside of the transfer (GIFT), zygote intrafallopian transfer uterus—usually in the fallopian tube, the ovary, (ZIFT), tubal embryo transfer, egg and embryo or the abdominal cavity. Ectopic pregnancy is a cryopreservation, egg and embryo donation, and dangerous condition that must receive prompt gestational surrogacy. medical treatment. ART cycle. An ART cycle starts when a woman Egg. A female reproductive cell, also called an begins taking fertility drugs or having her ovaries oocyte or ovum. monitored for follicle production. If eggs are produced, the cycle progresses to egg retrieval. Egg/Embryo banking cycle. An ART cycle started Retrieved eggs are combined with sperm to create with the intention of freezing (cryopreserving) all embryos. If fertilization is successful, at least one resulting eggs or embryos for potential future use.